维普期刊资源整合服务平台（V6.5）

维普中文期刊产品整合服务

8篇 您的检索式：作者名="Torabi P"

选中清除导出查看参考文献查看引证文献引用追踪共1页首页上一页第1页下一页末页 /1 跳转

		题名	作者	年代	出处	被引量
	1	CT of nonneoplastic hepatic vascular and perfusion disorders显示文摘	Torabi M Hosseinzadeh K Federie M P	2008	Radiograph- ics2008，28，7：	1
	2	Cen- tral memory self/tumor-reactive CD8 + T cells confer su- perior antitumor immunity compared with eVector memory T ceils显示文摘	Klebanoff C A Gattinoni L Torabi Parizi P	2005	Proc Natl Acad Sci USA2005，102，27：	1
	3	Experimental and theoretical assessment of brittle fracture in engineering components containing a sharp V-notch显示文摘	Ayatollahi M R Torabi A R Azizi P	2011	ExpMech2011，51，：	1
	4	Pharmacokinetics of liposomal amphotericin B in pleural fluid显示文摘	Moriyama B Torabi P Pratt AK	2010	Antimicrob Agents Chemother2010，54，4：	1
	5	Paroxetine vs pregabalin for the management of neuropathic pain in multiple sclerosis显示文摘AIM: To compare the effectiveness and tolerability of paroxetine vs pregabalin for the management of multiple sclerosis(MS)-induced neuropathic pain(NPP).METHODS: A randomized, flexible-dose open-label 8-wk study involving 21 relapsing-remitting MS patients with MS-induced NPP was conducted to evaluate the effectiveness and tolerability of pregabalin versus paroxetine for pain management. The trial included a 3-wk dose titration phase followed by a 5-wk stable dose phase. Primary outcome measures included daily patient-reported pain intensity as measured using a 100 mm visual analogue scale(VAS pain) and daily impact of pain on daily activities(VAS impact). Hierarchical regression modeling was conducted on each outcome to determine if within person VAS trajectory for pain and impact differed across study groups, during 56 d follow-up. RESULTS: Attrition rates were significantly greater(P < 0.001) in the paroxetine versus pregabalin study group(70% vs 18.2%, respectively). Average study duration between study groups also significantly differed(P < 0.001). Paroxetine participants completed an average of 27.3 d of treatment vs 49.5 d in the pregabalin group, with the majority of patients withdrawing due to adverse events. Due to the high attrition rates in the paroxetine study arm, the investigators stopped the study prior to achieving complete recruitment. As such, no significant differences between pregabalin and paroxetine study arms were noted for the primary outcome measures(VAS pain, VAS impact). Comparative assessment of baseline patient characteristics also revealed no significant differences between the study arms. CONCLUSION: High attrition rates associated with paroxetine use suggest that it be used with caution for MS-induced NPP. Efficacy outcomes could not be assessed due to attrition.	Dana A Turcotte Malcolm Doupe Mahmoud Torabi Andrew J Gomori Karen Ethans Farid Esfahani Katie Galloway Michael P Namaka	2014	World Journal of Anesthesiology2014，3，2：	1
	6	In vitro selection of a sodium-specific DNAzyme and its application in intracellular sensing显示文摘	Torabi SF Wu P Mcghee CE	2015	Proc Natl Acad Sci USA2015，112，19：	1
	7	Retinoicacid controls the homeostasis of pre-cDC-derived splenic and intestinal dendritic cells 显示文摘	Klebanoff CA Spencer SP Torabi Parizi P	2013	J Exp Med2013，210，10：	1
	8	Central memory self/tumor-reactive CD8 + T cells confer superior antitumor immunity compared with effector memory T cells 显示文摘	Klebanoff CA Gattinoni L Torabi - Parizi P	2005	Proc Nat! Acad Sci USA2005，102，27：	1

返回顶部每页显示：

共1页首页上一页第1页下一页末页 /1 跳转

goolge学术搜索-维普

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1　渝公网安备 50019002500403号　违法和不良信息举报中心

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费